论文部分内容阅读
哈尔滨医科大学第一临床学院肝脾外科专家姜洪池教授与博士研究生代文杰共同完成的一项国家自然科学基金课题 ,近日初战告捷。这项“人白细胞介素 - 10与人肝再生增强因子融合基因靶向表达与抗肝硬变作用”研究 ,在世界上首次采用融合基因防治肝硬化 ,成果喜人。曾成功实施世界
Harbin Medical University, the first clinical college of liver and spleen surgery expert Professor Jiang Hongchi and doctoral student Dai Wenjie jointly completed a national natural science fund project, the early victory. This “human interleukin-10 and human liver regeneration enhanced factor fusion gene-targeted expression and anti-liver cirrhosis” study, the world’s first use of fusion gene for cirrhosis, the results were gratifying. Had successfully implemented the world